About
Third Pole Therapeutics is a biopharmaceutical company focused on developing novel therapies targeting nitric oxide pathways for treating diseases related to vascular and inflammatory conditions.
Explore Third Pole Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.